Outcome of patients with HIV-related germ cell tumours: a case–control study

Tom Powles(Queen Mary University of London), T. Oliver(Aarhus University Hospital), Jonathan Shamash(Queen Mary University of London), Annemiek de Ruiter(ViiV Healthcare (Spain)), Gedske Daugaard(Copenhagen University Hospital), Martin Fisher(Northwell Health), Mark Bower(Chelsea and Westminster Hospital), Justin Stebbing(Anglia Ruskin University), Margaret Johnson(Duke University), Mark Nelson(University of Tasmania), J. Ong(St Bartholomew's Hospital), Brian Gazzard(British HIV Association), Jane Anderson(Baylor College of Medicine)
British Journal of Cancer
March 30, 2004
10.1038/sj.bjc.6601762
Cited by 26

Related Papers

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|3.7k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
|Journal of Clinical Oncology|2005|1.9k